Druggable genome in attention deficit/hyperactivity disorder and

Druggable genome in attention deficit/hyperactivity disorder and

Druggable genome in attention deficit/hyperactivity disorder and

Druggable genome in attention deficit/hyperactivity disorder and

Transcriptome‐wide gene expression in a rat model of attention deficit hyperactivity disorder symptoms: Rats developmentally exposed to polychlorinated biphenyls - Sazonova - 2011 - American Journal of Medical Genetics Part B: Neuropsychiatric

Druggable genome in attention deficit/hyperactivity disorder and

FDA-Approved Drugs to Treat ADHD Journal of Psychosocial Nursing and Mental Health Services

Druggable genome in attention deficit/hyperactivity disorder and

The role of glutamate receptors in attention‐deficit/hyperactivity disorder: From physiology to disease - Huang - 2019 - American Journal of Medical Genetics Part B: Neuropsychiatric Genetics - Wiley Online Library

Druggable genome in attention deficit/hyperactivity disorder and

Workshop: Genes to Biology: Integrative Systematic Approaches for Revealing Biological Functions of Psychiatric Risk Genes and Alleles - National Institute of Mental Health (NIMH)

Druggable genome in attention deficit/hyperactivity disorder and

Genes, Free Full-Text

Druggable genome in attention deficit/hyperactivity disorder and

Tile plot of the association between druggable genes and ADHD (p

Druggable genome in attention deficit/hyperactivity disorder and

New research explores the unique effects of ADHD medications on Drosophila brain cells

Druggable genome in attention deficit/hyperactivity disorder and

Linking GWAS to pharmacological treatments for psychiatric disorders

Druggable genome in attention deficit/hyperactivity disorder and

Attention-Deficit Hyperactivity Disorder: Genetic, Pharmacogenetic, and Metabolomic Insights

Druggable genome in attention deficit/hyperactivity disorder and

Insights into attention-deficit/hyperactivity disorder from recent genetic studies, Psychological Medicine

Druggable genome in attention deficit/hyperactivity disorder and

Examining the shared etiology of psychopathology with genome-wide association studies

Druggable genome in attention deficit/hyperactivity disorder and

Pharos – A Torch to Use in Your Journey In the Dark Genome